We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Concurrent Training and Prediabetes Control

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03502304
Recruitment Status : Completed
First Posted : April 18, 2018
Last Update Posted : May 31, 2018
Sponsor:
Collaborators:
Universidad de Los Lagos
Healthcare Center Tomas Rojas
Universidad del Rosario
Information provided by (Responsible Party):
Universidad Santo Tomas

Tracking Information
First Submitted Date  ICMJE April 9, 2018
First Posted Date  ICMJE April 18, 2018
Last Update Posted Date May 31, 2018
Actual Study Start Date  ICMJE June 10, 2017
Actual Primary Completion Date April 9, 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: April 17, 2018)
  • Fasting glucose [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from Baseline in fasting glucose
  • Lipoproteins [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from baseline in lipoproteins
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: April 17, 2018)
  • Body mass [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from Baseline in body mass
  • Waist circumference [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from Baseline in waist circumference
  • Fat mass [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from Baseline in fat mass
  • Lean mass [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from Baseline in lean mass
  • Heart rate at rest [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from Baseline in heart rate at rest
  • Six minutes walking test [ Time Frame: Baseline and 20-weeks immediately after the interventions ends ]
    Change from Baseline in six minutes walking test
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Concurrent Training and Prediabetes Control
Official Title  ICMJE Concurrent Training and Prediabetes Comorbidities: An Analysis of Non-responders Using Clinical Cutoff Points
Brief Summary Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities. Thus, is yet unknown the effects and influence of the concurrent training (CT) eliciting responders (R) and non-responders (NR) cases (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes).
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Behavioral
Masking: Single (Investigator)
Primary Purpose: Prevention
Condition  ICMJE Metabolic Disturbance
Intervention  ICMJE Behavioral: Endurance training plus resistant training
CT in women with prediabetes and co-morbidities associated. Exercise will be performed at three sessions per week. Post statistical analyses will be including analyses by the 2 groups proposed. All sessions will be supervised by an exercise physiologist during 20-weeks.
Study Arms  ICMJE
  • Active Comparator: Control group
    No-exercise
    Intervention: Behavioral: Endurance training plus resistant training
  • Experimental: Endurance training plus resistant training
    To concurrent training (endurance training plus resistant training, RT) program will be use cycle ergometers adapted for obese adults (OXFORDTM, model BE2601, OXOFORD Inc, Santiago, Chile) were used. Prior to the CT intervention, all subjects were familiarized (during 3 sessions) with the training protocols. The CT intervention included 3 weekly sessions of both ET and RT. The core part of each session included RT followed by ET exercises (for 50 and 30 minutes, respectively) and was preceded and followed by a 5-minute warm-up and cool-down with callisthenic movements.
    Intervention: Behavioral: Endurance training plus resistant training
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: April 17, 2018)
28
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE April 9, 2018
Actual Primary Completion Date April 9, 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Written informed consent.
  • Interested in improving health and fitness.

Exclusion Criteria:

  • Cardiovascular contraindications to exercise,
  • History of stroke, asthma or chronic obstructive pulmonary disease,
  • Muscle-skeletal disorders, and
  • Smoking.
  • A compliance rate to the exercise program ≥ 70% was required for the participants in the intervention group to be included in the statistical analyses.
Sex/Gender  ICMJE
Sexes Eligible for Study: Female
Ages  ICMJE 30 Years to 59 Years   (Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Chile
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03502304
Other Study ID Numbers  ICMJE 9042018
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Universidad Santo Tomas
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Universidad Santo Tomas
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE
  • Universidad de Los Lagos
  • Healthcare Center Tomas Rojas
  • Universidad del Rosario
Investigators  ICMJE
Principal Investigator: Cristian Alvarez, PhD Universidad de Los Lagos
PRS Account Universidad Santo Tomas
Verification Date May 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP